A EST RA CT Human lymphocytes and human skin fibroblasts isolated in vilro from subjects carrying the Mediterranean variant of glucose-6-phosphate dehydrogenase (CCPD) exhibit an 86-87% decrease of this enzymatic activity. This is coupled with 51% and 61% decreases of the NADPH/NADP+ ratio in the GCPD-deficient human lymphocytes (HL) and human skin fibroblasts (HSF), respectively. There also occurs a 63-67% decrease of the hexose monophosphate shunt (HMS) in the deficient cells. Incubation with 0.1 mM methylene blue stimulates the HMS of normal HL 15-fold and that of deficient lymphocytes only 2.4-fold. These figures are, respectively, 7 and 2.2 in the case of HSF. This behavior of CCPDdeficient HL and HSF is coupled with an increase of the resistance to the cell death induced by benzo(a)pyrene (BP). This effect is mimicked by the incubation of normal HSF with dehydroepiandrosterone (DEA) which strongly inhibits GCPD. In contrast, no differences between normal and deficient HSF occur as a result of the effect of methylnitrosourea (MNU), a carcinogen that does not need metabolic activation.
. These observations agree with the results of Schwartz and Perantoni (6) which indicate that DEA protects in vitro cultured cells from the toxic and transforming effects of aflatoxin B and 7,12 -dime t h y 1 be nzo (a) a n t h racen e. Furthermore, DEA and epiandrosterone inhibit the metabolism of the latter carcinogen by in vitro growing rat liver epithelial-like cells (6) .
Based on these results, the hypothesis has been suggested that the NADPH cellular pool regulates the cytochrome P450-dependent BP activation in human cells. As a first approach to this problem we have studied the ability of human lymphocytes (HL) and HSF from normal males or males carrying the Mediterranean variant of GWD to metabolize BP.
MATERIALS AND METHODS
Blood and skin samples were obtained from normal males or males carrying the Mediterranean variant of GGPD. Lymphocytes were isolated by a shock-lysing procedure (7) . The cells were suspended in RPMI 1640 medium supplemented with 20 mM HEPES (4-( 2 -hydroxyethyl)-1 -piperazineethanesulfonic acid) buffer (pH 7.4) . 10% heat-inactivated human plasma, heparin (60 U/ml), penicillin (100 U/ml), and streptomycin (100 pg/ ml). Before use they were incubated 4 days at 37°C in the presence of 1% PHA (phytohemagglutinin) and pokeweed. In order to isolate fibroblasts, the skin was removed and treated according to the method of Sly and Grubb (7) . The cells used in the various experiments were subcultured from primary cultures in Dulbecco's modified Eagle's medium containing 13% calf serum, penicillin (100 U/ml), and streptomycin (100 pglml), maintained in an atmosphere of 5% COz in air at 37°C. Doubling times in our culture conditions were 25 and 96 hr for HL and HSF, respectively. No differences between normal and glucose-6-phosphate (G6P)-deficient cells with respect to growth rate and morphology were observed.
For the quantitation of carcinogen-resistant cells, lymphocyte suspensions (loG cells)
were incubated 4 days in the presence of mitogens in 50-ml Erlenmeyer flasks and then exposed to 20 pg of BP for the times indicated. At the end of the exposure period, the lymphocytes were centrifuged 10 min at 800 x g and washed in fresh medium. Nonviable cells were detected by the trypan blue exclusion test and counted. The cells were then stained with May-Grumwald and counted. Nonviable cell number was subtracted from the total cell number to obtain the number of viable cells. HSF were plated in microtiters at 5000 cells/cm2 and exposed after a %day period to 20 pg of either BP or methylnitrosourea (MNU) for 48 hr. At this time, unattached fibroblasts were removed with the medium: the number of viable cells was then determined as above. G6PD and hexose monophosphate shunt (HMS) activities and pyridine nucleotide content were determined as in a previous report (3) . NADPH-cytochrome c reductase of HL and HSF homogenates was assayed as previously published (9) ; when indicated 1 mM NADP+and G6P substituted NADPH. Homogenates were prepared from cell suspensions (8 X lO'/ml) by using a Polytron homogenizer (15 sec at 2.5 with a PTA7 probe). BP hydroxylase was determined by the radioactive assay developed by Van Cantfort et al. (lo), using HL suspensions (lo8 cells/ml) as the source of enzyme. The enzyme was induced by 2 pg/ml of benzo(a)anthracene for 24 hr before the assay.
The conversion of BP to water-soluble metabolites was performed as in a previous report (4) on confluent HSF cultures or on HL maintained for 4 days in the presence of mitogens. The cells were incubated 24 hr with 2 pg/ml of benzo(a)anthracene before use.
The mutagenicity experiments were performed by using his-Salmonella typhimurium TA 100 (11) . The bacteria were grown overnight in Oxoid Nutrient Broth No. 2, centrifuged 10 min at 2000 x g and resuspended in Hanks medium free of Caz+ and Mg2+ to a titer of 3.5 x 107/ml. The incubations with intact lymphocytes were performed for 3 hr at 37°C in the dark, with 25 p~ BP and 50 pl of bacterial suspension, in a final volume of 1 ml. Then, 2 ml of 45°C warm top agar were added and the mixture was poured onto Petri dishes containing 1.5% agar and Vogel-Bonner E medium with 2% glucose. After incubation at 37°C for 72 hr the number of his+ revertant colonies was counted. Bacteria incubated without lymphocytes were used to calculate spontaneous retromutation.
Protein determination was performed as previously published (4) .
RESULTS

Susceptibility of Human Cells to the Carcinogen Toxicity
As shown in Table I , lymphocyte cultures from donors carrying the Mediterranean GGPD variant contained a significantly higher number of BP-resistant cells than controls. A similar behavior was observed for HSF carrying the variant enzyme ( Table 11 ). Interestingly, the treatment with DEA increased the HSF resistance to the BP toxic effect. It should be noted that no difference between the two types of fibroblasts was observed with MNU, a carcinogen that does not need metabolic activation (12). Table 111 shows that the GGPD specific activity was only 12.5% and 14.9% that of con- a Following a 3-day induction of blast formation with PHA and pokeweed, lymphocytes were exposed for 4 days to fresh medium containing 20 pg/ml of BP. After this, the number of viable cells was examined. The data arc means of two determinations for each donor. trol, respectively, for fibroblasts and lymphocytes carrying the Mediterranean enzyme variant. The decrease of GGPD was coupled with a 2.0-and 2.9-fold decrease of NADPHI NADP' ratio in lymphocytes and fibroblasts, respectively (Table IV) . Table V shows HMS activity after 9-hr incubation of lymphocytes with [I-"C]glucose. It appears that HMS was 63% reduced in the GGPD-deficient cells incubated without methylene blue. The addition of methylene blue resulted in a 15-fold increase of HMS in normal HL against only a 2.4-fold increase in Mediterranean 0.81 f 0.23 (9) Following a 3-hr attachment period, washed cultures were exposed to carcinogens (20 pglrnl) for 48 hr. After this time, the number of viable cells remaining in the dishes were examined. The data are means f S.D. of at least four determinations with the cells of each donor, except for DEA-treated cells, with which only two determinations were performed. MNU-containing medium was changed every 12 hr. 
The Hexose Monophosphate Shunt of Human Lymphocytes and Fibroblasts
Variant
TOXICOLOGIC PATHOLOGY
G6PD-deficient
.' HL were cultured 24 hr in 50-ml flasks with a center well. Then the medium was removed and DME containing 20 mM HEPES buffer (pH 7.4), 5 mM glucose, and 1 pCi of [I-"C]glucose was added. 0.2 ml of 3 M NaOH was placed in the center well and the flasks were closed with rubber caps. After 9 hr, the incubation medium was deproteinized by injecting HCIO4 through the rubber caps. The radioactivity of Na,'TO, was taken as a measure of HMS activity. [2-"C]Glucose WJS substituted for [I-"C]glucose for estimates of the amounts of recycling through the HMS. " Means f S.D.; three donors of each GGPD type were used.
' Methylene blue (0.1 mM) was added together with the labeled glucose. test, deficient versus normal: p < 0.001. the deficient cells. As a consequence, a 93% HMS decrease occurred in methylene bluetreated HL. HMS was also measured in growing fibroblasts (Table VI) . After 4 days in vitro, the HMS activity was 26% lower in the G6PDdeficient cells. Methylene blue induced a 6.4fold increase of HMS activity in normal HSF and a 2.4-fold increase in the deficient ones, which means that in the latter cells an 88% HMS decrease occurred.
NADPH-Cytochrome c Reductase
In order to assess the ability of normal and G6PD-deficient cells to reduce cytochrome P450, the NADPH-cytochrome c (P450) reductase of HL homogenates was tested in a reaction mixture containing NADPH or NADP', G6P, and endogenous G6PD. As illustrated in Fig. 1 , when externally added NADPH was present in the reaction mixture, no differences were observed between the two types of lymphocytes as concerns the rate of cytochrome c reduction. However, when NADP' and G6P substituted for NADPH, a sharp decrease of the cytochrome c reduction rate occurred in the homogenates of deficient HL as compared to control. This difference was completely abolished by the addition of exogenous GGPD to the reaction mixture. .'The HMS activity of HSF was determined as described in the legend of Table V, except that HSF was cultured 4 days before the addition of labeled glucose and then 4 more days before deproteinization. Data taken from Feo ef a/. (4) .
" Means f S.D.; five donors of each GGPD type were used.
' Methylene blue (0.1 mM) was added together with the labeled glucose.
"t test, deficient versus normal: p < 0.001. Similar results have been obtained with HSF from different normal and GGPD-deficient donors (not shown).
Benzo(a)pyrene Metabolism
In order to investigate the capacity of GGPD-deficient cells to metabolize BP, post-mitochondria1 fractions from normal and deficient HL, induced with benzo(a)anthracene, were compared for the BP-hydroxylating ac- tivity. Two reaction systems were used: a complete system containing exogenous NADP+, GGP, and GGPD and an incomplete system in which GGPD was omitted. It is known that the BP hydroxylase activity undergoes great variations among individuals. However, when this enzymatic activity was studied in normal and GGPD-deficient HL having comparable activities in the complete reaction system (Fig. 2) , the effect of different GGPD contents could be investigated by using the incomplete reaction system. In this system, the production of hydroxylated BP compounds increased during 30-min incubation of the postmitochondrial fraction of normal lymphocytes, while it greatly decreased with the same fraction of GGPD-deficient HL (Fig.   2 ).
The decreased BP-metabolizing activity of GGPD-deficient cells was also documented by studying the BP conversion to water-soluble products. Table VII shows that after 48 hr of incubation there occurred a 93% decrease of the production of water-soluble compounds by GGPD-deficient HL. In the case of HSF the decrease was 44% after 24 hr and 58% after 48 hr of incubation. An analogous decrease of the water-soluble compound synthesis was documented with normal DEA-treated HSF.
Production of Mutagenic BP Metabolites
The incubation of intact cells with carcinogens leads to the production of metabolites that cause retromutation of his-S . iyphimurium (1 3). The ability of benzo(a)anthracene- HL (20 X lO"/ml) were suspended in RPMl 1640 medium containing human plasma and mitogens. 2-ml aliquots were plated in multidishes (1.9 cm'). On the 3rd day the cultures received 2 pg/ml of benzo(a)anthracene and, 24 hr later, lo-' mM ['HIBP. After 24 hr, the medium was collected and extracted twice with 5 ml of acetone and 5 m l of hexane. 1-ml aliquots of the aqueous phase were used to determine the radioactivity of water-soluble metabolites. HSF (3500/cm2) were suspended in DME medium containing calf serum, plated in microtiters, and fed every 3 days. On the 6th day, the cultures of normal HSF received a medium containing 0.1 mht DEA in ethanol or ethanol alone. After 5 more days, the cultures of both types of HSF received a medium containing 2 @nI of benzo(a)anthracene and, 24 hr later, lo-' mh4 ['HIBP. After 24 and 48 hr, the medium was collected and the amount of water-soluble metabolites was induced, GGPD-deficient HL to produce mutagenic compounds for S. typhimurium TA 100 was compared with that of normal or DEA-treated HL. As shown in Fig. 3 the number of revertants per plate underwent a 60% decrease with GGP-deficient HL as compared to control. A 40% decrease was observed when normal lymphocytes were incubated with DEA. Interestingly, the revertant number was very low in DEA-treated HL carrying the Mediterranean enzyme variant, in which no G6PD activity was detectable.
DISCUSSION
The basic abnormality in GGPD deficiency could be a decreased synthesis of enzyme molecules, the production of enzyme molecules with a low catalytic activity and the production of enzyme molecules with a reduced stability (14). In persons carrying the Mediterranean GGPD variant, a great enzyme lability, coupled with a decrease of catalytic activity, has been found (15, 16) . This could explain the decrease of the HL and HSF GGPD activity even though these cells exhibit a protein-synthesizing apparatus. Leukocyte G6PD activity, nearly normal in subjects with the GdA-type of enzyme (17), is greatly reduced in persons with the Mediterranean enzyme variant (18) .
The decrease of G6PD activity in HL and HSF carrying the Mediterranean enzyme variant is coupled with a decrease of the NADPH/NADP+ ratio. This indicates that other cellular NADPH producing enzymatic reactions, such as NADP+-dependent isocitrate dehydrogenase, malic enzym:, and transhydrogenation, cannot compensate for the decrease of GGPD in HL and HSF. The decrease of NADPH/NADP+ ratio should ~psult in a lower G6PD inhibition by NADPH (19) . However, this does not seem to compensate for the reduced GGPD activity in the cells carrying the Mediterranean enzyme variant. In fact, the HMS activity is significantly reduced in GGPD-deficient HL and HSF. Methylene blue, by causing the rapid oxidation of NADPH (20) , induces the HMS to occur under maximum oxidative stress. In the presence of methylene blue, the HMS activity is 15 and 9 times lower in the G6PD-deficient HL and HSF, respectively, compared to controls. This could indicate that NADPH produced by these cells, even though sufficient for steady state functions, as for instance the in vitro growth, would be inadequate when the reduced nucleotide is required for an actively functioning metabolic system. Thus, when the mixed function monooxygenase system is engaged in the metabolism of large amounts of BP, the effect of the decrease of the NADPH/NADP+ ratio should become evident. Accordingly, HL and HSF from G6PDdeficient donors are more resistant than normal cells to the BP toxic effect (1-4) (see also Table 11 ). Moreover, HSF carrying the Mediterranean enzyme variant are less prone than normal HSF to be transformed in vitro by BP (4). Interestingly, the toxicity for HSF of MNU, a carcinogen that does not need metabolic activation (12), does not seem to be modulated by the GGPD activity of these cells.
Our data seem to indicate that the protective effect of GGPD deficiency against the toxic and transforming effects of BP is linked to a decreased ability of deficient cells to metabolize BP. The homogenates of deficient cells are less able than control to reduce cytochrome c in a reaction system containing a large excess of G6P and NADP' which should maximally activate endogenous GGPD. Although some differences between cytochromes P450 and cytochrome c should exist as concerns their sensitivity to NADPH pool changes, it could be reasonably assumed that the NADPH-linked reducing power of GGPD-deficient cells is lower than that of normal cells. If so, a decrease of BP metabolism should occur in the deficient cells. Our data indicate that when the hydroxylating activity is assayed in the absence of exogenous GGPD, BP hydroxylation is indeed lower in deficient benzo(a)pyrene-induced HL, as compared to control. Further support to the above hypothesis is given by the decrease of the BP transformation to water-soluble products and mutagenic compounds in the G6PDdeficient cells. It also should be noted that the similarity between human cells carrying the Mediterranean enzyme variant and the cells treated with DEA, relative to their susceptibility to BP toxicity and their ability to metabolize BP, suggests that GGPD activity is involved in the resistance of these cells to xenobiotics.
In vitro experiments do not reproduce in vivo' conditions. However, it is interesting to note that a decrease of tumor incidence has been demonstrated in GGPD-deficient patients (21) (22) (23) . Long term p .~. treatment with DEA inhibit the formation of spontaneous cancer in mice (24) . In addition, urinary production rates of DEA and DEA sulfate are significantly reduced in breast cancer patients compared to controls (25) . Premenopausal women with benign breast cancer, who are considered under risk of subsequently developing breast cancer (26) , have a lower plasma level of DEA (27) . Men and women with a variety of types of cancer (28-30) have also been found to have a lower plasma concentration of DEA sulfate than controls.
